• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Creation of molecular therapy for gastrointestinal cancer using inhibition of intra cellular molecular transport and regulation of epigenetics

Research Project

Project/Area Number 20390351
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Digestive surgery
Research InstitutionChiba University

Principal Investigator

MATSUBARA Hisahiro  Chiba University, 大学院・医学研究院, 教授 (20282486)

Co-Investigator(Kenkyū-buntansha) AKUTSU Yasunori  千葉大学, 大学院・医学研究院, 講師 (00375677)
Project Period (FY) 2008 – 2010
Project Status Completed (Fiscal Year 2010)
Budget Amount *help
¥19,370,000 (Direct Cost: ¥14,900,000、Indirect Cost: ¥4,470,000)
Fiscal Year 2010: ¥5,590,000 (Direct Cost: ¥4,300,000、Indirect Cost: ¥1,290,000)
Fiscal Year 2009: ¥5,590,000 (Direct Cost: ¥4,300,000、Indirect Cost: ¥1,290,000)
Fiscal Year 2008: ¥8,190,000 (Direct Cost: ¥6,300,000、Indirect Cost: ¥1,890,000)
Keywords消化器癌 / 細胞内分子移動 / エピジェネティクス / 分子治療 / micro RNA / エピジネティクス
Research Abstract

In order to create new molecular therapy for gastrointestinal cancer, we have planed the regulation of gene transduction, translation and protein synthesis. Furthermore, we have tried inhibition of intracellular molecular transport for the same purpose. We found that new molecule which inhibit enzyme for genetic expression have good efficieny for gene therapy. And this molecule was revealed anti-tumor action. The regulation of molecular transportation between nuclear and cytoplasm have induced cell death. These new molecules are important seeds for translational research and extremely useful for new development of molecular therapy for gastrointestinal cancer.

Report

(4 results)
  • 2010 Annual Research Report   Final Research Report ( PDF )
  • 2009 Annual Research Report
  • 2008 Annual Research Report
  • Research Products

    (23 results)

All 2011 2010 2009 2008

All Journal Article (17 results) (of which Peer Reviewed: 8 results) Presentation (6 results)

  • [Journal Article] COX2 Expression Predicts Resistance To Chemoradiotherapy in Esophageal Squamous Cell Carcinoma.2011

    • Author(s)
      Akutsu Y, Hanari N, Yusup G, Komatsu-Akimoto A,Ikeda N, Mori M, Yoneyama Y, Endo S, Miyazawa Y, Matsubara H
    • Journal Title

      Ann Surg Oncol.

    • Related Report
      2010 Final Research Report
  • [Journal Article] Correlation between gp96 expression and the surgical outcome in patients with esophageal squamous cell carcinoma.2011

    • Author(s)
      Akutsu Y, Matsubara H, Kano M, Usui A, Yoneyama Y, Ikeda N, Komatsu A, Yusup G
    • Journal Title

      Ann Surg Oncol. 18(3)

      Pages: 832-7

    • Related Report
      2010 Final Research Report
  • [Journal Article] An alternative splicing isoform of eukaryotic initiation factor 4H promotes tumorigenesis in vivo and is a potential therapeutic target for human cancer.2011

    • Author(s)
      Wu D, Matsushita K, Matsubara H, Nomura F, Tomonaga T
    • Journal Title

      Int J Cancer. 128(5)

      Pages: 1018-30

    • Related Report
      2010 Final Research Report
  • [Journal Article] COX2 Expression Predicts Resistance to Chemoradiotherapy in Esophageal Squamous Cell Carcinoma.2011

    • Author(s)
      Akutsu Y, Hanari N, Yusup G, ほか, Matsubara H.
    • Journal Title

      Ann Surg Oncol

      Volume: (Epub)

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Correlation between gp96 expression and the surgical outcome in patients with esophageal squamous cell carcinoma.2011

    • Author(s)
      Akutsu Y, Matsubara H, Kano M, etal.
    • Journal Title

      Ann Surg Onco1

      Volume: 18 Pages: 832-7

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] miR-145, miR-133a and miR-133b : Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.2010

    • Author(s)
      Kano M, Seki N, Kikkawa N, Fujimura L, Hoshino I, Akutsu Y, Chiyomaru T, Enokida H, Nakagawa M, Matsubara H
    • Journal Title

      Int J Cancer. 127(12)

      Pages: 804-14

    • Related Report
      2010 Final Research Report
  • [Journal Article] Recent advances in histone deacetylase targeted cancer therapy.2010

    • Author(s)
      Hoshino I, Matsubara H
    • Journal Title

      Surg Today. 40(9)

      Pages: 809-15

    • NAID

      10027397377

    • Related Report
      2010 Final Research Report
  • [Journal Article] CHAP31 induces apoptosis only via the intrinsic pathway in human esophageal cancer cells.2010

    • Author(s)
      Murakami K, Matsubara H, Hoshino I, Akutsu Y, Miyazawa Y, Matsushita K, Sakata H, Nishimori T, Usui A, Kano M, Nishino N, Yoshida M
    • Journal Title

      Oncology. 78(1)

      Pages: 62-74

    • Related Report
      2010 Final Research Report
  • [Journal Article] Viral shedding after p53 adenoviral gene therapy in 10 cases of esophageal cancer.2010

    • Author(s)
      Kawahira H, Matsushita K, Shiratori T, Shimizu T, Nabeya Y, Hayashi H, Ochiai T, Matsubara H, Shimada H
    • Journal Title

      Cancer Sci. 101(1)

      Pages: 289-91

    • NAID

      10027200634

    • Related Report
      2010 Final Research Report
  • [Journal Article] miR-145, miR-133a and miR-133b : Tumor-suppressive miRNAs target FSCNI in esophageal squamous cell carcinoma.2010

    • Author(s)
      Kano M, Seki N, Kikkawa N, ほか, Matsubara H.
    • Journal Title

      In t J Cancer

      Volume: 127 Pages: 2804-2814

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] CHAP31 induces apoptosis only via the intrinsc pathway in human esophageal cancer cells.2010

    • Author(s)
      Murakami K, Matsubara H, Hoshino I, et al.
    • Journal Title

      Oncology 78

      Pages: 62-74

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Effects of carbon-ion radiotherapy combined with a novel histone deacetylase inhibitor, cyclic hydroxamic-acid-containing peptide 31 in human esophageal squamous cell carcinoma.2009

    • Author(s)
      Kano M, Yamada S, Hoshino I, Murakami K, Akutsu Y, Sakata H, Nishimori T, Usui A, Miyazawa Y, Kamada T, Tsujii H, Matsubara H
    • Journal Title

      Anticancer Res. 29(11)

      Pages: 4433-8

    • Related Report
      2010 Final Research Report
  • [Journal Article] Effects of carbon-ion radiotherapy combined with a novel histone deacetylase inhibitor, cyclic hydroxamic-acid-containing peptide 31 in human esophageal squamous cell carcinoma.2009

    • Author(s)
      Kano M, Yamada S, Hoshino I, ほか, Matsubara H.
    • Journal Title

      Anticancer Res. 29

      Pages: 4433-4438

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Combined effects of p53 gene therapy and leptomycin B in human esophageal squamous cell carcinoma.2008

    • Author(s)
      Hoshino I, Matsubara H, Komatsu A, Akutsu Y, Nishimori T, Yoneyama Y, Murakami K, Sakata H, Matsushita K, Miyazawa Y, Brooks R, Yoshida M, Ochiai T
    • Journal Title

      Oncology. 75(1-2)

      Pages: 113-9

    • Related Report
      2010 Final Research Report
  • [Journal Article] Role of histone deacetylase inhibitor in adenovirus-mediated p53 genetherapy in esophageal cancer.2008

    • Author(s)
      Hoshino I, Matsubara H, Akutsu Y, et al.
    • Journal Title

      Anticancer Res. 28

      Pages: 665-671

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Combined effects of p53 gene therapy and leptomycin B in human esophageal sauamous cell carcinoma.2008

    • Author(s)
      Hoshino I, Matsubara H, Komatsu A, Akutsu Y, et al.
    • Journal Title

      Oncology 75

      Pages: 113-119

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Neoadjuvant chemoradiation therapy for the treatment of esophageal carcinoma.2008

    • Author(s)
      Matsubara H
    • Journal Title

      Int J Clin Oncol. 13

      Pages: 474-478

    • NAID

      10023919830

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Presentation] Fra-1 is an independent prognostic factor in esophageal squamous cell carcinoma and related to cell proliferation, migration and invasion in vitro.2010

    • Author(s)
      Matsubara H, Usui A, Akutsu Y, et al
    • Organizer
      22nd EORTC-NCI-AACR Symposium on MolecularTargets and Cancer Therapeutics
    • Place of Presentation
      Berlin, Germany
    • Year and Date
      2010-11-19
    • Related Report
      2010 Final Research Report
  • [Presentation] Fra-1 is an independent prognostic factor in esophageal squamous cell carcinoma and related to cell proliferation, migration and invasion in vitro.2010

    • Author(s)
      Matsubara H, Usui, A, Akutsu, Y, etal.
    • Organizer
      22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
    • Place of Presentation
      Berlin, Germany
    • Year and Date
      2010-11-19
    • Related Report
      2010 Annual Research Report
  • [Presentation] CHAP31 Induces Apoptosis Only via the Intrinsic Pathway in Human Esophageal Cancer Cells.2009

    • Author(s)
      Matsubara H, Murakami K, Akutsu Y, Nishino N, Yoshida M
    • Organizer
      8th AACR-JCA Joint Conference
    • Place of Presentation
      Kona, Hawaii, USA
    • Year and Date
      2009-10-16
    • Related Report
      2010 Final Research Report
  • [Presentation] CHAP31 Induces Apoptosis Only via the Intrinsic Pathway in Human Esophageal Cancer Cells2009

    • Author(s)
      Hisahiro Matsubaral, Kentaro Murakami, Yasunori Akutsul, Norikazu Nishino, Minoru Yoshida
    • Organizer
      8^<th> AACR-JCA Joint Conference
    • Place of Presentation
      Kona, Hawaii, USA
    • Year and Date
      2009-10-16
    • Related Report
      2009 Annual Research Report
  • [Presentation] 食道癌の外科治療と新規治療法の現況2008

    • Author(s)
      松原久裕
    • Organizer
      日本癌学会腫瘍別シンポジウム
    • Place of Presentation
      名古屋
    • Year and Date
      2008-10-30
    • Related Report
      2010 Final Research Report
  • [Presentation] 食道癌の外科治療と新規治療法の現況2008

    • Author(s)
      松原久裕
    • Organizer
      腫瘍別シンポジウム
    • Place of Presentation
      名古屋
    • Year and Date
      2008-10-30
    • Related Report
      2008 Annual Research Report

URL: 

Published: 2008-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi